Source link : https://newshealth.biz/health-news/targeted-lung-cancer-drug-aces-confirmatory-trial-in-frontline-setting/
CHICAGO — An oral targeted drug reduced the risk of disease progression or death by 35% compared with chemotherapy when given as first-line treatment for non-small cell lung cancer (NSCLC) patients with EGFR exon 20 insertions, a randomized trial showed. In patients with nonsquamous NSCLC, median progression-free survival (PFS) reached 10.3 months with sunvozertinib (Zegfrovy) […]
The post Targeted Lung Cancer Drug Aces Confirmatory Trial in Frontline Setting first appeared on News Health.
—-
Author : News Health
Publish date : 2026-05-29 21:44:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8